December 10, 2012

expert reaction to the end of the HFEA mitochondria consultation

Launched at an SMC briefing in September 2012, the public consultation into emerging techniques designed to prevent mitochondrial disease closed on the 7th December.

Dr Marita Pohlschmidt, Director of Research at the Muscular Dystrophy Campaign, said:

“We are glad to have been part of this consultation, which has been an opportunity both to put the science behind pronuclear transfer under the microscope and to present the harsh realities of life with mitochondrial disease.

“For the patients and their families affected by mitochondrial disease, we have heard that safety is a key concern about this IVF technique. Scientists have tested the technique in the laboratory and are now working to optimise and refine each stage of the process. We know that there is both the commitment and funding available to ensure this happens.

“The Muscular Dystrophy Campaign is optimistic that the public will share this view. There is still work to be done before it can move towards clinical trials. However, if the results are the clinical trials are successful, we may have a treatment offering invaluable life choices to women living with a cruel condition.”

HFEA public consultation: http://www.hfea.gov.uk/6896.html